Oral liquid alendronate formulations
US5462932A · kind A · utility
43Cited by
7References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 17, 1994 |
| Grant date | Oct 31, 1995 |
| Priority date | — |
| Expiry date | May 17, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a therapy protocol for treating and for preventing bone loss in patients who have difficulty in swallowing by administering a liquid formulation of alendronate which can be easily swallowed. Also described are pharmaceutical dosage forms of a syrup, aqueous solution, a solution formed from a reconstituted powder, of alendronate, for carrying out the therapeutic method.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.